What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Gary Cutter spends much of his time researching Multiple sclerosis, Surgery, Internal medicine, Clinical trial and Randomized controlled trial.
His work deals with themes such as Physical therapy, Central nervous system disease and MEDLINE, which intersect with Multiple sclerosis.
His Surgery research includes elements of Myasthenia gravis, Glatiramer acetate, Young adult and Confidence interval.
His Internal medicine study frequently links to other fields, such as Gastroenterology.
Gary Cutter has included themes like Predictive value of tests, Magnetic resonance imaging, Psychometrics and Expanded Disability Status Scale in his Clinical trial study.
The Randomized controlled trial study combines topics in areas such as Anesthesia, Relative risk, Placebo and Gestation.
His most cited work include:
- Defining the clinical course of multiple sclerosis: The 2013 revisions (1374 citations)
- Cardia: study design, recruitment, and some characteristics of the examined subjects (1150 citations)
- Development of a multiple sclerosis functional composite as a clinical trial outcome measure (947 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Multiple sclerosis, Internal medicine, Clinical trial, Physical therapy and Randomized controlled trial.
His Multiple sclerosis research includes themes of Physical medicine and rehabilitation, Central nervous system disease, Pediatrics and Cohort.
His Cohort study frequently links to adjacent areas such as Cohort study.
Gary Cutter combines subjects such as Placebo, Surgery and Oncology with his study of Internal medicine.
His study on Clinical trial is mostly dedicated to connecting different topics, such as Adverse effect.
In most of his Physical therapy studies, his work intersects topics such as Quality of life.
He most often published in these fields:
- Multiple sclerosis (27.51%)
- Internal medicine (27.01%)
- Clinical trial (17.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (27.01%)
- Multiple sclerosis (27.51%)
- Clinical trial (17.22%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Multiple sclerosis, Clinical trial, Randomized controlled trial and Physical medicine and rehabilitation.
His study looks at the relationship between Internal medicine and fields such as Oncology, as well as how they intersect with chemical problems.
In his work, he performs multidisciplinary research in Multiple sclerosis and Outcome measures.
His Randomized controlled trial research is multidisciplinary, relying on both Intervention and Physical therapy.
His research in Physical therapy focuses on subjects like Telehealth, which are connected to Pulmonary rehabilitation.
The Clinical endpoint study which covers Expanded Disability Status Scale that intersects with Placebo.
Between 2018 and 2021, his most popular works were:
- The prevalence of MS in the United States: A population-based estimate using health claims data. (264 citations)
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. (146 citations)
- Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants. (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Internal medicine, Multiple sclerosis, Randomized controlled trial, Physical medicine and rehabilitation and Clinical trial are his primary areas of study.
His research ties Oncology and Internal medicine together.
His study in Multiple sclerosis is interdisciplinary in nature, drawing from both Physical therapy, Quality of life and Protocol.
His Physical therapy study combines topics in areas such as COPD and Depression.
His Physical medicine and rehabilitation research incorporates elements of Verbal memory, Cognition, Disease and Aerobic exercise.
His studies in Clinical trial integrate themes in fields like Placebo and Expanded Disability Status Scale.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
